Literature DB >> 3029232

Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma.

M Pérez, T Cabrera, M A Lopez Nevot, M Gomez, F Peran, F Ruiz-Cabello, F Garrido.   

Abstract

HLA class I and II antigen expression was studied in 19 cases of primary infiltrating ductal carcinoma of the breast. An indirect immunofluorescence technique was used on cryostat sections with monoclonal antibodies directed against HLA class I and II monomorphic determinants. Of the 19 cases studied, 17 were positive for class I antigen expression and two were negative. Class I HLA antigen expression was found to be clearly heterogeneous: in ten of these tumours more than 75% of the cells were class I positive; in two the percentage was decreased to between 50% and 75%; in five tumours it was less than 50%. With respect to class II HLA antigen expression, eight breast tumours were totally negative while two were strongly positive (50-75%) and the nine remaining cases were less than 25% positive. In addition, radioassay techniques were employed to determine the presence of oestrogen and progestagen receptors. The distribution of these receptors was not correlated with HLA class I or II antigen expression, nor could any relationship be demonstrated between the degree of histological differentiation of the tumours and their invasiveness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3029232     DOI: 10.1111/j.1744-313x.1986.tb01108.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  13 in total

1.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.

Authors:  P Wang; F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.

Authors:  P Möller; T Mattfeldt; C Gross; P Schlosshauer; A Koch; K Koretz; G Moldenhauer; M Kaufmann; H F Otto
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Authors:  María A Garrido; Teresa Rodriguez; Svitlana Zinchenko; Isabel Maleno; Francisco Ruiz-Cabello; Ángel Concha; Nicolás Olea; Federico Garrido; Natalia Aptsiauri
Journal:  Immunogenetics       Date:  2018-08-25       Impact factor: 2.846

5.  Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.

Authors:  A Maiorana; A M Cesinaro; R A Fano; G Collina
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

6.  Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.

Authors:  F Ruiz-Cabello; M A Lopez Nevot; J Gutierrez; M R Oliva; C Romero; A Ferron; F Esteban; C Huelin; M A Piris; C Rivas
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

7.  Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.

Authors:  F Vánky; G Stuber; J Willems; K Sjöwall; B Larsson; K Böök; T Ivert; A Péterffy; E Klein
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.

Authors:  F Vánky; P Wang; M Patarroyo; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Authors:  H O Wintzer; M Benzing; S von Kleist
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

10.  HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.

Authors:  M A López-Nevot; F Esteban; A Ferrón; J Gutiérrez; M R Oliva; C Romero; C Huelin; F Ruiz-Cabello; F Garrido
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.